98 related articles for article (PubMed ID: 27677595)
1. Loss of Dnmt3a induces CLL and PTCL with distinct methylomes and transcriptomes in mice.
Haney SL; Upchurch GM; Opavska J; Klinkebiel D; Appiah AK; Smith LM; Heavican TB; Iqbal J; Joshi S; Opavsky R
Sci Rep; 2016 Sep; 6():34222. PubMed ID: 27677595
[TBL] [Abstract][Full Text] [Related]
2. Dnmt3a Is a Haploinsufficient Tumor Suppressor in CD8+ Peripheral T Cell Lymphoma.
Haney SL; Upchurch GM; Opavska J; Klinkebiel D; Hlady RA; Roy S; Dutta S; Datta K; Opavsky R
PLoS Genet; 2016 Sep; 12(9):e1006334. PubMed ID: 27690235
[TBL] [Abstract][Full Text] [Related]
3. Promoter Hypomethylation and Expression Is Conserved in Mouse Chronic Lymphocytic Leukemia Induced by Decreased or Inactivated Dnmt3a.
Haney SL; Upchurch GM; Opavska J; Klinkebiel D; Hlady RA; Suresh A; Pirruccello SJ; Shukla V; Lu R; Costinean S; Rizzino A; Karpf AR; Joshi S; Swanson P; Opavsky R
Cell Rep; 2016 May; 15(6):1190-201. PubMed ID: 27134162
[TBL] [Abstract][Full Text] [Related]
4. Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation.
Mayle A; Yang L; Rodriguez B; Zhou T; Chang E; Curry CV; Challen GA; Li W; Wheeler D; Rebel VI; Goodell MA
Blood; 2015 Jan; 125(4):629-38. PubMed ID: 25416277
[TBL] [Abstract][Full Text] [Related]
5. DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS.
Herek TA; Bouska A; Lone W; Sharma S; Amador C; Heavican TB; Li Y; Wei Q; Jochum D; Greiner TC; Smith L; Pileri S; Feldman AL; Rosenwald A; Ott G; Lim ST; Ong CK; Song J; Jaffe ES; Wang GG; Staudt L; Rimsza LM; Vose J; d'Amore F; Weisenburger DD; Chan WC; Iqbal J
Blood; 2022 Sep; 140(11):1278-1290. PubMed ID: 35639959
[TBL] [Abstract][Full Text] [Related]
6. The de novo methyltransferases DNMT3a and DNMT3b target the murine gammaherpesvirus immediate-early gene 50 promoter during establishment of latency.
Gray KS; Forrest JC; Speck SH
J Virol; 2010 May; 84(10):4946-59. PubMed ID: 20200245
[TBL] [Abstract][Full Text] [Related]
7. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia.
Baer C; Claus R; Frenzel LP; Zucknick M; Park YJ; Gu L; Weichenhan D; Fischer M; Pallasch CP; Herpel E; Rehli M; Byrd JC; Wendtner CM; Plass C
Cancer Res; 2012 Aug; 72(15):3775-85. PubMed ID: 22710432
[TBL] [Abstract][Full Text] [Related]
8. Loss of Dnmt3a and endogenous Kras(G12D/+) cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogenesis.
Chang YI; You X; Kong G; Ranheim EA; Wang J; Du J; Liu Y; Zhou Y; Ryu MJ; Zhang J
Leukemia; 2015 Sep; 29(9):1847-56. PubMed ID: 25801914
[TBL] [Abstract][Full Text] [Related]
9. Aberrant Promoter Hypomethylation in CLL: Does It Matter for Disease Development?
Upchurch GM; Haney SL; Opavsky R
Front Oncol; 2016; 6():182. PubMed ID: 27563627
[TBL] [Abstract][Full Text] [Related]
10. Variants of
Božić T; Frobel J; Raic A; Ticconi F; Kuo CC; Heilmann-Heimbach S; Goecke TW; Zenke M; Jost E; Costa IG; Wagner W
Life Sci Alliance; 2018 Dec; 1(6):e201800153. PubMed ID: 30582132
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide methylation profiling of Peripheral T-cell lymphomas identifies TRIP13 as a critical driver of tumor proliferation and survival.
Nowialis P; Tobon J; Lopusna K; Opavska J; Badar A; Chen D; Abdelghany R; Pozas G; Fingeret J; Noel E; Riva A; Fujiwara H; Opavsky R
Res Sq; 2024 Feb; ():. PubMed ID: 38464090
[TBL] [Abstract][Full Text] [Related]
12. Transition of mouse de novo methyltransferases expression from Dnmt3b to Dnmt3a during neural progenitor cell development.
Watanabe D; Uchiyama K; Hanaoka K
Neuroscience; 2006 Oct; 142(3):727-37. PubMed ID: 16973295
[TBL] [Abstract][Full Text] [Related]
13. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
Halldórsdóttir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Göransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
Am J Hematol; 2012 Apr; 87(4):361-7. PubMed ID: 22374828
[TBL] [Abstract][Full Text] [Related]
14. De novo DNA methyltransferase is essential for self-renewal, but not for differentiation, in hematopoietic stem cells.
Tadokoro Y; Ema H; Okano M; Li E; Nakauchi H
J Exp Med; 2007 Apr; 204(4):715-22. PubMed ID: 17420264
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma.
Rinaldi A; Mensah AA; Kwee I; Forconi F; Orlandi EM; Lucioni M; Gattei V; Marasca R; Berger F; Cogliatti S; Cavalli F; Zucca E; Gaidano G; Rossi D; Bertoni F
Br J Haematol; 2013 Oct; 163(2):194-204. PubMed ID: 23961875
[TBL] [Abstract][Full Text] [Related]
16. MDM2 overexpression deregulates the transcriptional control of RB/E2F leading to DNA methyltransferase 3A overexpression in lung cancer.
Tang YA; Lin RK; Tsai YT; Hsu HS; Yang YC; Chen CY; Wang YC
Clin Cancer Res; 2012 Aug; 18(16):4325-33. PubMed ID: 22733537
[TBL] [Abstract][Full Text] [Related]
17. New insights into the pathogenesis of chronic lymphocytic leukemia.
Klein U; Dalla-Favera R
Semin Cancer Biol; 2010 Dec; 20(6):377-83. PubMed ID: 21029776
[TBL] [Abstract][Full Text] [Related]
18. Distinct patterns of global promoter methylation in early stage chronic lymphocytic leukemia.
Ronchetti D; Tuana G; Rinaldi A; Agnelli L; Cutrona G; Mosca L; Fabris S; Matis S; Colombo M; Gentile M; Recchia AG; Kwee I; Bertoni F; Morabito F; Ferrarini M; Neri A
Genes Chromosomes Cancer; 2014 Mar; 53(3):264-73. PubMed ID: 24347044
[TBL] [Abstract][Full Text] [Related]
19. Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.
Rodríguez-Vicente AE; Díaz MG; Hernández-Rivas JM
Cancer Genet; 2013 Mar; 206(3):49-62. PubMed ID: 23531595
[TBL] [Abstract][Full Text] [Related]
20. Elevated Dnmt3a activity promotes polyposis in Apc(Min) mice by relaxing extracellular restraints on Wnt signaling.
Samuel MS; Suzuki H; Buchert M; Putoczki TL; Tebbutt NC; Lundgren-May T; Christou A; Inglese M; Toyota M; Heath JK; Ward RL; Waring PM; Ernst M
Gastroenterology; 2009 Sep; 137(3):902-13, 913.e1-11. PubMed ID: 19454286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
